- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Cardiology Organizations Bracing For Major Revenue Drop Because of COVID-19
Information comes from a survey MedAxiom, an American College of Cardiology company, conveyed.
MedAxiom, an American College of Cardiology company, surveyed its members from March 24-28 to assess the effect of the COVID-19 outbreak on cardiovascular organizations. Representatives of 89 organizations responded. The majority (77.5%) have 11 or more cardiologists.
Here are some of the results:
• Between 50% and 75% of the respondents expected to see their organization’s second-quarter revenues drop by almost in half (47.3%). Between 25% and 50% of the respondents expected to see second-quarter revenues fall by a little over a third (37.8%).
• Between 25% and 50% of the respondents had put 29.9% of their staff on paid leave and 10.7% on unpaid leave.
• Over 20% of respondents have closed or are planning to close 50% or more of their clinics.
• Most programs are seeing a reschedule rate of between 50% to 75% in cardiovascular procedures. Between 25% and 50% have rescheduled close to half (42.5%) of their imaging studies.
• Nearly 70% of cardiovascular programs are utilizing advanced practice providers for telehealth services.
Drug Discount Programs Poised to Change with New Tech, Pharma Execs Survey Finds
April 22nd 2024It is somewhat mind-boggling in 2024 that more than one-third of pharma organizations still rely on manual entry of data into Excel spreadsheets to track duplicate discounts that can cost millions of dollars a year in lost revenue
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
